NAMS Stock

NewAmsterdam Pharma Company NV (NAMS) produces promising results

Kenneth Phillips

While NewAmsterdam Pharma Company NV has overperformed by 5.90%, investors are advised to look at stock chart patterns for technical ...

Is NewAmsterdam Pharma Company NV (NAMS) a good investment opportunity?

Arcelia Reed

While NewAmsterdam Pharma Company NV has overperformed by 8.41%, investors are advised to look at stock chart patterns for technical ...

A closer look at NewAmsterdam Pharma Company NV’s (NAMS) current quarter earnings projections

Cameron Mitchell

NewAmsterdam Pharma Company NV (NAMS)’s stock has witnessed a price hike of 1.58% from the previous close with its current ...

US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.